Angela M Sucha, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 109 W 11th St, Neligh, NE 68756 Phone: 402-887-5440 |
Brenda Sue Korth-wurdinger, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1108 R St, Neligh, NE 68756 Phone: 402-887-4681 |
News Archive
Collaboration in prostate cancer translational research in Europe is not only vital to sustain the progress achieved in recent years but also to streamline current efforts between researchers and clinicians and avoid duplication or overlaps. This was amongst the goals of the two-day Prostate Cancer Translational Research in Europe (PCTRE) Meeting which opened today in Amsterdam, The Netherlands.
No one likes clingy people, but "clingy" blood platelets may offer hope for millions of people with rheumatoid arthritis. According to new research findings published in The Journal of Leukocyte Biology, a sub population of immune cells (lymphocytes) known to play a significant role in rheumatoid arthritis has platelets attached to their surface.
The U.S. Food and Drug Administration's (FDA) Office of Criminal Investigations (OCI) has announced that The Purdue Frederick Company, Inc. has agreed to pay more than $700 million to resolve criminal charges and civil liabilities in connection with several illegal schemes to promote, market and sell OxyContin, a powerful prescription pain reliever that the company produces.
New research from the Institute for Sustainability, Health and Environment (ISHE) at the University of the West of England, shows that Adult Social Care can become more environmentally sustainable, more economical and still meet social objectives, with the right policies and strategies in place.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
› Verified 5 days ago